Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3365 results

Sort By:

Open Surgical, Modified Seldinger's and US Techniques for Jugular Central Line Insertion in Infants

Study ID: NCT06862492
Start Date: 2025-08-21
End Date: 2025-08-21
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

35

Intervention / Treatment

Open surgical cut down technique

Modified Seldinger's technique

Closed Ultrasound guided CVC insertion

Sponsor

So much university

Source: clinicaltrials.gov

Share:
Add to list

The AIRTIVITY® Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Study ID: NCT06872892
Start Date: 2025-06-16
End Date: 2028-10-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1680

Intervention / Treatment

BI 1291583

Placebo matching BI 1291583

Sponsor

Boehringer Ingelheim

Source: clinicaltrials.gov

Share:
Add to list

Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)

Study ID: NCT06586892
Start Date: 2025-10-31
End Date: 2032-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Radiotherapy followed by chemotherapy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Transdiagnostic Metacognitive Therapy Compared to Disorder-Specific Cognitive-Behavioral Therapy for Anxiety Disorders

Study ID: NCT06937892
Start Date: 2025-06
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

86

Intervention / Treatment

Transdiagnostic metacognitive therapy

Disorder-specific cognitive-behavioral therapy

Sponsor

Benjamin Bohman

Source: clinicaltrials.gov

Share:
Add to list

Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

Study ID: NCT05873192
Start Date: 2025-09-30
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

ADT

Enzalutamid

Carcolor

Degarelix

Luprolide

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

International Observatory of Antiphospholipids Treated by Direct Oral Anticoagulants

Study ID: NCT06929182
Start Date: 2025-07-01
End Date: 2035-07-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

"non-high risk" thrombotic APS patients treated with DOAC

Sponsor

Central Hospital, Nancy, France

Source: clinicaltrials.gov

Share:
Add to list

Comparison the Analgesic Efficacy of Ultrasonographic Bilateral TAP and Anesthetic Infiltration Into the Surgery Field for Laparoscopic Unilateral TEP Herniorrhaphy

Study ID: NCT06894420
Start Date: 2025-05-04
End Date: 2025-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Surgeon-Initiated Local Anesthetic

Transversus abdominis plane (TAP) block

Sponsor

Başakşehir Çam and Sakura City Hospital

Source: clinicaltrials.gov

Share:
Add to list

Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)

Study ID: NCT06916520
Start Date: 2025-09
End Date: 2027-04
Study Type

Interventional

Study Phase

Phase4

No. of Participants

300

Intervention / Treatment

Prasugrel 5 mg

Dual Antiplatelet (DAPT) Therapy

Sponsor

J.P.S Henriques

Source: clinicaltrials.gov

Share:
Add to list

Addressing the Double Burden of Malnutrition in Guatemala

Study ID: NCT06750120
Start Date: 2025-09-01
End Date: 2029-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1532

Intervention / Treatment

Family food ration

Optimal weight counseling

Enhanced Usual Care

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Study ID: NCT06856226
Start Date: 2025-05-07
End Date: 2028-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

88

Intervention / Treatment

Arm 1

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list